SBIR/STTR Research Award
Evaluation of National Video Directly Observed Therapy Implementation
Award amount
$995,241Program and phase
SBIR · Phase IIAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- EMOCHA MOBILE HEALTH INC.
- Proposal award date
- 2018-08-05
- Contract end date
- 2021-03-31
- UEI
- FHWGEP6NNLG1
- Solicitation number
- PA17-302
- Topic code
- 102
Research abstract
PROJECT SUMMARYemocha Mobile HealthInc and Johns Hopkins investigators have developed a userfriendlyHIPAA compliant application for asynchronous video directly observed therapyDOTmiDOTThe miDOT platform consists of a patientfacing mobile application where patients can recordvideos of themselves taking medication at their convenience and a providerfacing web portalthat allows providers to monitor adherence and progressvisualize datagenerate reportsviewside effects reportsand automatically send SMS medication remindersThe platformrepresents a patientcentered strategy for improving adherence support and overcomes costand logistical barriers to traditional DOT while maintaining patient autonomy and respectOur SBIR Phase I efforts successfully demonstratedtechnological feasibility of using miDOTfor TB treatment monitoringmiDOT is acceptable and preferred by patients and providers forTB treatment andmiDOT is effective at ensuring high levels of adherence and treatmentcompletionHoweverseveral key knowledge deficits existFirstour Phase I efforts focused onpatients with prior demonstration of good adherence in one stateIt is now imperative todemonstrate that miDOT would be used and effective in a broader patient populationSecondcurrent videoDOT efforts have focused on active TB patientshoweverpublic health authoritieshave also prioritized treatment for the estimatedmillion people in the US living with latent TBinfectionLTBIA short course regimen for LTBI is recommended to prevent progression toactive TBand consists ofmonths of weekly isoniazidINHand rifapentineorHPadministered under DOThoweveruptake has been limited due to this DOT requirementwhichis not logistically feasible with such high patient volumesAlternative selfadministered LTBItreatments can be prescribedbut are lengthymonthsand have poor completion ratesFinallythere is a need to define best practices for miDOT integration and adoption into currentTB programsOur SBIR Phase II goal is to guide programmatic scaleup throughimplementation research while building the necessary technical infrastructure to allow thesystem scale commercially to meet the needs of larger patient populationsPROJECT NARRATIVEThe proposed study will evaluate a nationally representative implementation study on videodirectly observed therapyDOTamong tuberculosisTBpatientsVideo DOT offers the benefitof patient and provider convenience by removing the need for frequentinperson visits and hasthe potential to reduce stigma while improving treatment completion in a more cost effectivemanner than traditional inperson DOTThe proposal will build the technical architecturenecessary to scale the technology in public and private commercial sectors
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)
- Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program
- Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients
- Feasibility of mHealth technology-enabled service for remote observed therapy of methadone and COVID-19 screening for patients in an opioid treatment program
- Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer